USP volunteers help shape the future of drug manufacturing
Consistent quality. Greater access. They’re what patients deserve and what USP strives to ensure across the globe through the development of public quality standards.
When a problem puts millions of lives at risk, costs economies billions of dollars and undermines decades of hard-earned health progress, it deserves prompt and strategic attention. I’m describing the consequences of poor-quality medicines – a worldwide problem that deserves worldwide attention.
USP was founded nearly 200 years ago by eleven doctors who wanted to ensure that the nation had access to quality medicines. They put together the first pharmacopeia, a book of recipes for making tinctures, extracts, and other medicines.
The opioid crisis in the U.S. seems to be part of nearly every news broadcast and news site today. And based on the number of people affected by this crisis, serious conversations about how to help are more important than ever.
Dr. Wesley (Wes) Workman, USP Volunteer and Chair, General Chapters–Biological Analysis Expert Committee reflects on his volunteer role at USP and his work with what he refers to as the "dream team" of the heparin world.
Today, we join the global health community in marking World Malaria Day. As we reflect on the major strides being made against this deadly disease, we also recognize that critical obstacles remain.
An appreciation of science, scientists, and the questions they ask. Read more.